• Users Online: 195
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2017  |  Volume : 2  |  Issue : 3  |  Page : 162-166

Prevalence, knowledge, and attitude toward complementary and alternative medicine use among patients with chronic hepatitis C in Upper Egypt

Department of Tropical Medicine and Gastroenterology, Faculty of Medicine, Assiut University, Assiut, Egypt

Correspondence Address:
Zeinab R Mohammed
Department of Tropical Medicine and Gastroenterology, Faculty of Medicine, Assiut University, Assiut
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/JCMRP.JCMRP_34_17

Rights and Permissions

Background Complementary and alternative medicine (CAM) encompasses different types of treatments and procedures that are based on traditions and are not scientifically sound; however, they are still used to 'complement' physician-prescribed drugs. Unfortunately, we lack local studies about CAM usage in patients with chronic hepatitis C (CHC) in Egypt. Aim The aim was to establish CAM prevalence among patients with CHC attending Assuit University Hospital and explore the knowledge and attitude toward using CAM among patients with CHC while using the interferon-based therapy and direct-acting antiviral drugs (DAAs). Patients and methods A cross-sectional survey using a screening questionnaire was used to collect data from patients attending Assiut University Hospital from April 2015 to April 2016. Results Of 750 patients, knowledge about CAM was positive among 610 (81.3%) patients, a positive attitude toward CAM was seen among 570 (76%) patients, and 479 (63.9%) patients stated using CAM. Of the 250 patients who used DAAs, 194 (77.6%) have used CAM, and 19 (9.7%) of them would continue on CAM after the use of DAAs. Conclusion A total of 479 (63.9%) patients used CAM in the study (285 undergoing interferon-based therapy and 194 at DAAs). Approximately, two-thirds of patients have used more than one type of CAM during the course of their disease. A small percentage (9.7%) of patients is still willing to continue using CAM even after the use of DAAs.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded109    
    Comments [Add]    

Recommend this journal